Inovio Pharmaceuticals, Inc.
INO
$1.68
$0.053.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.51M | 50.80M | 47.55M | 68.36M | 94.11M |
| Total Receivables | 500.00 | 978.60K | 840.30K | 1.31M | 1.20M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.61M | 3.40M | 4.31M | 2.22M | 2.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 61.12M | 55.18M | 52.70M | 71.89M | 97.83M |
|
|
|||||
| Total Current Assets | 61.12M | 55.18M | 52.70M | 71.89M | 97.83M |
| Net Property, Plant & Equipment | 9.07M | 9.70M | 10.45M | 11.09M | 11.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.01M | 2.01M | 2.01M | 1.98M | 1.98M |
| Total Assets | 74.31M | 69.39M | 68.24M | 87.27M | 113.20M |
|
|
|||||
| Total Accounts Payable | 2.62M | 5.90M | 5.48M | 5.52M | 6.44M |
| Total Accrued Expenses | 9.16M | 10.76M | 12.15M | 9.68M | 13.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.82M | 2.74M | 2.66M | 2.58M | 2.50M |
| Total Finance Division Other Current Liabilities | 29.07M | 50.43M | 11.42M | 9.54M | 13.26M |
| Total Other Current Liabilities | 29.07M | 50.43M | 11.42M | 9.54M | 13.26M |
| Total Current Liabilities | 43.67M | 69.82M | 31.71M | 27.33M | 35.33M |
|
|
|||||
| Total Current Liabilities | 43.67M | 69.82M | 31.71M | 27.33M | 35.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.55M | 7.28M | 8.00M | 8.70M | 9.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 50.21M | 77.11M | 39.71M | 36.02M | 44.69M |
|
|
|||||
| Common Stock & APIC | 1.84B | 1.81B | 1.80B | 1.80B | 1.80B |
| Retained Earnings | -1.82B | -1.82B | -1.77B | -1.75B | -1.73B |
| Treasury Stock & Other | -638.00K | -647.40K | -661.70K | -661.30K | -675.70K |
| Total Common Equity | 24.10M | -7.72M | 28.53M | 51.25M | 68.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.10M | -7.72M | 28.53M | 51.25M | 68.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.10M | -7.72M | 28.53M | 51.25M | 68.50M |
|
|
|||||